Indication

Paget's disease of bone

Paget's disease of bone is a chronic skeletal disorder marked by focal dysregulation of the bone remodeling cycle. Read more about Paget's disease of bone

44 drugs 31 manufacturers

Advertisement

Drugs that treat it

Common Paget's disease of bone therapies.

Showing 37–44 of 44 drugs

Filter & compare in the drug finder →Opens the drug finder with Paget's disease of bone preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Paget's disease of bone.

Paget's disease of bone is a chronic skeletal disorder marked by focal dysregulation of the bone remodeling cycle.

It predominantly affects adults over the age of 50 and involves one or more localized skeletal sites, most commonly the pelvis, spine, femur, and skull.

Pathophysiologically, hyperactive osteoclasts drive excessive bone resorption followed by disorganized osteoblastic new bone formation, producing an irregular mosaic of weakened, structurally compromised, and highly vascularized bone.

While often asymptomatic, affected individuals may develop deep bone pain, skeletal deformities, secondary osteoarthritis, fractures, and neurological compressions such as hearing loss.

Personalize your experience

Follow Paget's disease of bone and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it